Hypertension Diagnostics Financials
We strongly advise to harness Hypertension Diagnostics fundamental analysis to find out if markets are presently mispricing the company. Simply put you can make use of it to find out if Hypertension Diagnostics is indeed mispriced or if you can make any profits on it by purchasing it and then waiting for the market to recognize its mistake and reprise the security. We were able to collect and analyze data for twenty-eight available reported financial drivers for Hypertension Diagnostics, which can be compared to its competitors.
Hypertension |
Understanding current and past Hypertension Diagnostics Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Hypertension Diagnostics' financial statements are interrelated, with each one affecting the others. For example, an increase in Hypertension Diagnostics' assets may result in an increase in income on the income statement.
Hypertension Diagnostics Stock Summary
Hypertension Diagnostics, Inc. designs, develops, manufactures, and markets proprietary noninvasive medical devices that detect subtle changes in the elasticity of arteries in the United States and internationally. Hypertension Diagnostics, Inc. was founded in 1988 and is based in Richmond Hill, Canada. Hypertension Diag operates under Shell Companies classification in the United States and is traded on OTC Exchange.Specialization | Healthcare, Medical Devices |
Instrument | USA Pink Sheet View All |
Exchange | PINK Exchange |
ISIN | US44914V1044 |
CUSIP | 44914V104 44914V203 |
Location | Minnesota; U.S.A |
Business Address | 550 Highway 7 |
Sector | Health Care Equipment & Supplies |
Industry | Health Care |
Benchmark | Dow Jones Industrial |
Website | www.hypertensiondiagnostics.com |
Phone | 404 449 6151 |
Currency | USD - US Dollar |
Hypertension Diagnostics Key Financial Ratios
Hypertension Diagnostics' financial ratios allow both analysts and investors to convert raw data from Hypertension Diagnostics' financial statements into concise, actionable information that can be used to evaluate the performance of Hypertension Diagnostics over time and compare it to other companies across industries.Return On Asset | 3.0E-4 | ||||
Beta | -0.92 | ||||
Z Score | -31.6 |
Hypertension Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Hypertension Diagnostics's current stock value. Our valuation model uses many indicators to compare Hypertension Diagnostics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Hypertension Diagnostics competition to find correlations between indicators driving Hypertension Diagnostics's intrinsic value. More Info.Hypertension Diagnostics is one of the top stocks in return on asset category among its peers. It also is one of the top stocks in profit margin category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Hypertension Diagnostics by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Hypertension Diagnostics' Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Other Consideration for investing in Hypertension Pink Sheet
If you are still planning to invest in Hypertension Diagnostics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Hypertension Diagnostics' history and understand the potential risks before investing.
Commodity Directory Find actively traded commodities issued by global exchanges | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |